For Immediate Release
January 12, 2026
Cranford, NJ – Today, Dr. Steve Brozak, President of WBB Securities, moderated a panel at Biotech Showcase 2026 titled “Working with ARPA-H: Federal Investment in Biotech & Healthcare Innovation.” The session took place in San Francisco and focused on the growing role of federal investment in advancing healthcare and biotechnology innovation.
The panel brought together senior leaders from the Advanced Research Projects Agency for Health (ARPA-H), each with deep experience spanning scientific research, government innovation, and product development:
- Jessica Green, PhD, Program Manager, Resilient Systems at ARPA-H, is an expert in microbiome science and healthy building design. Prior to joining ARPA-H, she was the founding CTO and CEO of Phylagen and a professor of biology at the University of Oregon, where she co-founded and directed the Biology and Built Environment Center.
- Natalie Kates, Acting Director, Scalable Solutions at ARPA-H, brings extensive experience in health-tech product development and public-sector innovation. She previously founded the Health team at the U.S. Digital Service and has led complex initiatives across multiple U.S. administrations.
- Paul Sheehan, PhD, Program Manager, Resilient Systems at ARPA-H, joined the agency from DARPA’s Biological Technologies Office. He previously spent 16 years at the U.S. Naval Research Laboratory and holds a doctorate in chemical physics from Harvard University. His research has been widely cited and featured in major publications.
The discussion explored how ARPA-H approaches federal investment in healthcare innovation and how industry participants can engage with government programs to help translate breakthrough science into meaningful, real-world impact.
Session details and the full Biotech Showcase agenda are available at:
https://informaconnect.com/biotech-showcase/agenda/1/?searchInput=#biotech-showcase-imperial-ballroom_working-with-arpa-h-federal-investment-in-biotech-healthcare-innovation_17-30
About WBB Securities.
WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily on the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of FINRA, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.
About Biotech Showcase.
Biotech Showcase, along with its family of events, Seed Showcase and TechBio Showcase, is a dedicated investor conference designed to provide private and micro-mid-cap biotechnology companies with the opportunity to present to and connect with investors and biopharmaceutical executives. With a roster of over 400 carefully selected presenting companies from across the globe, ranging from seed-stage startups to established multinational corporations, encompassing diverse fields such as platform technologies, therapeutic areas, digital health, devices, and diagnostics, these events attract investors wielding over USD 400 billion in capital and motivated strategic partners within the life science ecosystem.
